Literature DB >> 22226625

The elderly patient with surgically resected non-small cell lung cancer--a distinct situation?

William Sterlacci1, Richard Stockinger, Thomas Schmid, Johannes Bodner, Wolfgang Hilbe, Christian Waldthaler, Wilhelm Oberaigner, Alexandar Tzankov, Michael Fiegl.   

Abstract

The worldwide population shift towards older ages will inevitably lead to more elderly patients being diagnosed with cancer. Lung cancer is the number one cause for cancer mortality and surgical resection is the treatment of choice whenever possible. This study investigates whether elderly patients with non-small cell lung cancer (NSCLC) are characterized by distinct clinical and pathologic features and different clinical course after resection. Special emphasis is placed on disease recurrence, which is an important, but rarely described parameter for biological tumor behavior. Sex, stage, histology, differentiation grade, smoking status, performance status, hemoglobin, C-reactive protein, lactate dehydrogenase, Ki-67 index, recurrent disease and overall survival were analyzed in 383 surgically resected NSCLC patients. Calculations were performed comparing patients <70 to ≥70 years. A postoperative follow-up period of 15 years enabled detailed correlations. Rate of disease recurrence and disease-free survival did not differ between any age groups and was not influenced by clinico-pathologic parameters. Elderly patients with a Ki-67 index of >3% were associated with significantly decreased overall survival time when compared to younger patients (36.3 and 47.3 months respectively, p=0.029). The biological behavior of NSCLC as reflected by characteristics of disease recurrence is similar for surgically resected patients among different age groups and does not warrant specific recommendations for the elderly surgical patient. The Ki-67 index offers prognostic information for overall survival in the elderly. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226625     DOI: 10.1016/j.exger.2011.12.008

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  4 in total

1.  Treatment Approaches in 102 Elderly Patients With Non-Small Cell Lung Cancer.

Authors:  Sener Cihan; Hatice Odabas; Nuriye Yildirim Ozdemir; Dogan Yazilitas; Nalan Akgul Babacan
Journal:  World J Oncol       Date:  2015-02-14

2.  Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis.

Authors:  Meiying Guo; Butuo Li; Yishan Yu; Shijiang Wang; Yiyue Xu; Xindong Sun; Linlin Wang; Jinming Yu
Journal:  Cancer Med       Date:  2019-04-03       Impact factor: 4.452

3.  CD44 promotes cell proliferation in non-small cell lung cancer.

Authors:  Bo Hu; Yuanyuan Ma; Yue Yang; Lijian Zhang; Haibo Han; Jinfeng Chen
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

4.  Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study.

Authors:  Haisheng You; Mengmeng Teng; Chun Xia Gao; Bo Yang; Sasa Hu; Taotao Wang; Yalin Dong; Siying Chen
Journal:  Front Med (Lausanne)       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.